RIO DE JANEIRO, BRAZIL - More than 9,000 women living in Havana will be administered two doses of Soberana 02, plus a booster dose of Soberana Plus, the two drugs against the coronavirus developed by the Finlay Vaccine Institute (IFV).
Havana's provincial deputy director of Public Health Nilda Roca explained that only women in the second and third trimester of pregnancy and breastfeeding their babies will be included in the trial.
The combination of two doses of Soberana 02 with an extra dose of Soberana Plus has shown a 91.2% efficacy against the SARS-CoV-2 coronavirus in . . .